|
Volumn 40, Issue 1, 2000, Pages 49-57
|
Repaglinide in type 2 diabetes: A 24-week, fixed-dose efficacy and safety study
a b c c d |
Author keywords
[No Author keywords available]
|
Indexed keywords
GLUCOSE;
HEMOGLOBIN A1C;
PLACEBO;
REPAGLINIDE;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
FATIGUE;
FEMALE;
GASTROINTESTINAL SYMPTOM;
GLUCOSE BLOOD LEVEL;
HEADACHE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PAIN;
RANDOMIZED CONTROLLED TRIAL;
ADULT;
AGED;
BLOOD GLUCOSE;
CARBAMATES;
DIABETES MELLITUS, TYPE 2;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FASTING;
FEMALE;
HUMANS;
HYPOGLYCEMIC AGENTS;
MALE;
MIDDLE AGED;
PATIENT DROPOUTS;
PIPERIDINES;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 0033694392
PISSN: 00912700
EISSN: None
Source Type: Journal
DOI: 10.1177/00912700022008694 Document Type: Article |
Times cited : (91)
|
References (14)
|